Quantcast
Environmental News for a Healthier Planet and Life

Help Support EcoWatch

36 Beagles Could Die if DowDuPont Pesticide Test Isn’t Stopped, Investigation Reveals

Animals
36 Beagles Could Die if DowDuPont Pesticide Test Isn’t Stopped, Investigation Reveals
A beagle in a cage at an animal testing lab in France; beagles are often used in tests because of their friendly nature. Yves Forestier / Sygma via Getty Images

Thirty-six beagles are in danger of being euthanized at the end of a pesticide test, the Humane Society of the United States (HSUS) revealed Tuesday.

The beagles' potential fate was only one of several shocking revelations uncovered by an almost 100-day HSUS investigation into the testing of beagles and hounds at Charles River Laboratories in Michigan.


"The disturbing findings at this facility are sadly not unique. Experiments are happening at hundreds of laboratories each year throughout the country, with more than 60,000 dogs suffering. But that does not have to be the fate for these 36 beagles," HSUS President and CEO Kitty Block said in the press release.

The beagles are being used in a test by Corteva Agriscience™, the Agriculture Division of DowDuPont, to assess a new fungicide called Adavelt®. They are being force-fed the fungicide via gelatin capsules for one year, and will be killed in July 2019 to assess damage unless the test is stopped. The U.S. Environmental Protection Agency (EPA) used to require that fungicide be tested on dogs for one year, but abandoned the requirement a decade ago after scientists said it did not give useful information, HSUS explained in the investigation report.

However, the test is still technically required by Brazil's Agência Nacional de Vigilância Sanitária (ANVISA), which is why DowDuPont told HSUS they were conducting it. HSUS said it had received an email from ANVISA saying it would grant waivers to companies wishing to be exempt from the test. HSUS also asked for and received a formal, written confirmation of the policy. But DowDuPont's regulatory affairs division said that it needed confirmation from ANVISA on its product specifically, according to HSUS.

"For months we have been urging Dow to end the unnecessary test and release the dogs to us. We have gone to considerable lengths to assist the company in doing so, but we simply cannot wait any longer; every single day these caged dogs are being poisoned and are one day closer to being killed. We must turn to the public to join us in urging Dow to stop the test immediately and to work with us to get these dogs into suitable homes," Block said.

DowDuPont, for its part, released a statement saying it had been working with HSUS to persuade ANVISA to scrap the test requirement, and would stop the test as soon as the Brazilian agency confirmed it had done so.

"Animal testing is not something Dow undertakes lightly, but neither is it something the Company can discontinue when it is required by regulatory authorities," DowDuPont said.

In addition to the fungicide tests, the HSUS investigation, which ran from April to August 2018, uncovered other incidents including tests by Paredox Therapeutics and Above and Beyond NB LLC. The press release summarized the findings:

Among the beagles tested on, the Humane Society of the United States documented the horrible short life of one dog named Harvey who clearly sought attention by humans and was characterized by the laboratory staff as "a good boy."

Harvey was being used to test the safety of two substances when poured into the chest cavity in a study commissioned by Paredox Therapeutics. Hounds were also used when the protocol called for a larger dog breed, such as a study by Above and Beyond Therapeutics for surgical implantation of a device to pump drugs through the spinal canal. Charles River carried out tests on dogs for at least 25 companies during the time of the Humane Society of the United States investigation.

The HSUS is working to replace animal testing with more effective ways of assessing the harms and benefits of substances. It said that 95 percent of human drug tests fail even after promising animal results.

"We must bring science into the 21st century for the benefit of humans who desperately need treatment and for the dogs whose lives deserve to be spared," the investigation concluded.

Correction: A previous version of this article incorrectly stated that the University of Vermont supported the Paredox Therapeutics study. The post has been changed with the updated information from the Humane Society of the United States. Additionally, the article has been updated to reflect the fact that the fungicide test is being conducted by Corteva Agriscience™, the Agriculture Division of DowDuPont, not Dow AgroSciences, according to the companies updated statement.

People Have the Power - VOTE 2020

Climate-action nonprofit Pathway to Paris first launched in 2014 with an "intimate evening" of music and conversation after the People's Climate March in New York City.

Read More Show Less

EcoWatch Daily Newsletter

Heo Suwat Waterfall in Khao Yai National Park in Thailand. sarote pruksachat / Moment / Getty Images

A national park in Thailand has come up with an innovative way to make sure guests clean up their own trash: mail it back to them.

Read More Show Less

Trending

The 2020 presidential election poses a critical test of climate conservatives' willingness to put their environmental concerns before party politics. filo / Getty Images

By Ilana Cohen

Four years ago, Jacob Abel cast his first presidential vote for Donald Trump. As a young conservative from Concord, North Carolina, the choice felt natural.

But this November, he plans to cast a "protest vote" for a write-in candidate or abstain from casting a ballot for president. A determining factor in his 180-degree turn? Climate change.

Read More Show Less
Headquarters of the World Health Organization in Geneva amid the COVID-19 outbreak on Aug. 17, 2020. FABRICE COFFRINI / AFP via Getty Images

The World Health Organization (WHO) announced Monday that 64 high-income nations have joined an effort to distribute a COVID-19 vaccine fairly, prioritizing the most vulnerable citizens, as Science reported. The program is called the COVID-19 Vaccines Global Access Facility, or Covax, and it is a joint effort led by the WHO, the Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi, the Vaccine Alliance.

Read More Show Less
Exterior of Cold Tube demonstration pavilion. Lea Ruefenacht

By Gloria Oladipo

In the face of dangerous heat waves this summer, Americans have taken shelter in air conditioned cooling centers. Normally, that would be a wise choice, but during a pandemic, indoor shelters present new risks. The same air conditioning systems that keep us cool recirculate air around us, potentially spreading the coronavirus.

Read More Show Less

Support Ecowatch